Diacerein PCD Pharma Franchise Company

Cafoli Lifecare offers a Diacerein range of 5 formulations across capsules and tablets, manufactured in WHO-GMP certified facilities. Distributors serving orthopaedic and rheumatology prescribers can secure district-wise monopoly franchise rights for this disease-modifying osteoarthritis agent with full promotional support.

What is Diacerein?

Diacerein is a slow-acting, symptom- and structure-modifying anti-osteoarthritis drug that works by inhibiting interleukin-1 beta, a key mediator of cartilage breakdown and joint inflammation. It relieves osteoarthritis pain with an effect that builds over weeks and persists after stopping. Reference: PubChem - Diacerein.

Available Forms

The Cafoli Diacerein portfolio includes oral Capsules and Tablets, commonly combined with glucosamine and other joint-support agents. Contact us for current pack presentations and combinations.

Therapeutic Applications

Diacerein is prescribed for osteoarthritis, particularly of the knee and hip, to reduce pain and support joint-structure preservation. Prescribers include orthopaedic surgeons, rheumatologists, physiotherapists-referring physicians and general physicians.

Why Diacerein is a High-Potential Molecule for Distributors

Osteoarthritis affects a very large and ageing population in India, and diacerein-glucosamine combinations are widely prescribed for long, months-long maintenance courses. Its role as a chronic, structure-modifying joint therapy gives distributors dependable repeat volume in the high-demand orthopaedic and pain-management segment.

Why Choose Cafoli Lifecare

Cafoli Lifecare offers monopoly franchise rights, WHO-GMP certified manufacturing, DCGI-approved formulations, a network of 1000+ franchise partners across India, and free promotional inputs.

References

1. PubChem: Diacerein
2. PubMed: diacerein in osteoarthritis
3. MedlinePlus: Osteoarthritis